{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:49:12Z","timestamp":1782175752889,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2024A1515010318"],"award-info":[{"award-number":["2024A1515010318"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"crossref","award":["2024B03J1254"],"award-info":[{"award-number":["2024B03J1254"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-026-03788-1","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:56:54Z","timestamp":1777355814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of drug-coated balloon combined with stenting vs. stenting alone in the treatment of femoropopliteal artery lesions requiring bailout stenting"],"prefix":"10.1186","volume":"26","author":[{"given":"Haoliang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"18","key":"3788_CR1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa051303","volume":"354","author":"M Schillinger","year":"2006","unstructured":"Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879\u201388.","journal-title":"N Engl J Med"},{"issue":"3","key":"3788_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1358863X07079823","volume":"12","author":"T Zeller","year":"2007","unstructured":"Zeller T. Current state of endovascular treatment of femoro-popliteal artery disease. Vasc Med. 2007;12(3):223\u201334.","journal-title":"Vasc Med"},{"issue":"1","key":"3788_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1024\/0301-1526\/a000986","volume":"51","author":"A Boc","year":"2022","unstructured":"Boc A, Er\u017een B, Perme RL, Boc V. Bailout stenting in femoropopliteal arterial segment. Vasa. 2022;51(1):13\u20138.","journal-title":"Vasa"},{"issue":"9","key":"3788_CR4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"V Aboyans","year":"2018","unstructured":"Aboyans V, Ricco JB, Bartelink MEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763\u2013816.","journal-title":"Eur Heart J"},{"issue":"3","key":"3788_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","volume":"116","author":"H Krankenberg","year":"2007","unstructured":"Krankenberg H, Schl\u00fcter M, Steinkamp HJ, B\u00fcrgelin K, Scheinert D, Schulte KL, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10\u00a0cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116(3):285\u201392.","journal-title":"Circulation"},{"issue":"3","key":"3788_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","volume":"3","author":"JR Laird","year":"2010","unstructured":"Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3(3):267\u201376.","journal-title":"Circ Cardiovasc Interv"},{"issue":"21","key":"3788_CR7","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","volume":"115","author":"M Schillinger","year":"2007","unstructured":"Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115(21):2745\u20139.","journal-title":"Circulation"},{"issue":"5","key":"3788_CR8","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","volume":"4","author":"MD Dake","year":"2011","unstructured":"Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4(5):495\u2013504.","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"3788_CR9","first-page":"679","volume":"60","author":"SW de Boer","year":"2019","unstructured":"de Boer SW, de Vries J, Werson DA, Fioole B, Vroegindeweij D, Vos JA, et al. Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID Trial. J Cardiovasc Surg (Torino). 2019;60(6):679\u201385.","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"2","key":"3788_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jvs.2016.09.031","volume":"65","author":"KJ Ho","year":"2017","unstructured":"Ho KJ, Owens CD. Diagnosis, classification, and treatment of femoropopliteal artery in-stent restenosis. J Vasc Surg. 2017;65(2):545\u201357.","journal-title":"J Vasc Surg"},{"issue":"4","key":"3788_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.avsg.2012.09.005","volume":"27","author":"L Razzouk","year":"2013","unstructured":"Razzouk L, Aggarwal S, Gorgani F, Babaev A. In-stent restenosis in the superficial femoral artery. Ann Vasc Surg. 2013;27(4):510\u201324.","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"3788_CR12","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jvs.2016.05.073","volume":"64","author":"K Stavroulakis","year":"2016","unstructured":"Stavroulakis K, Torsello G, Manal A, Schwindt A, Hericks C, Stachmann A, et al. Results of primary stent therapy for femoropopliteal peripheral arterial disease at 7 years. J Vasc Surg. 2016;64(6):1696\u2013702.","journal-title":"J Vasc Surg"},{"issue":"3","key":"3788_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ultrasmedbio.2015.11.001","volume":"42","author":"M Gao","year":"2016","unstructured":"Gao M, Zhao X, Tao Y, Wang L, Xia M, Tong Z, et al. Incidence and Predictors of In-stent Re-Stenosis in the Superficial Femoral Artery: Evaluation of Long-Term Outcomes by Color Duplex Ultrasound. Ultrasound Med Biol. 2016;42(3):717\u201326.","journal-title":"Ultrasound Med Biol"},{"issue":"3","key":"3788_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jvs.2018.01.030","volume":"68","author":"K Qato","year":"2018","unstructured":"Qato K, Conway AM, Mondry L, Giangola G, Carroccio A. Management of isolated femoropopliteal in-stent restenosis. J Vasc Surg. 2018;68(3):807\u201310.","journal-title":"J Vasc Surg"},{"issue":"36","key":"3788_CR15","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700.","journal-title":"Eur Heart J"},{"issue":"13","key":"3788_CR16","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jcin.2023.05.048","volume":"16","author":"F Liistro","year":"2023","unstructured":"Liistro F. Is Drug-Coated Balloon the Real Winner for Femoropopliteal Artery Intervention? JACC Cardiovasc Interv. 2023;16(13):1651\u20133.","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"3788_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","volume":"9","author":"X Jia","year":"2016","unstructured":"Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F, et al. Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial. JACC Cardiovasc Interv. 2016;9(18):1941\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"3788_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jcin.2021.03.021","volume":"14","author":"R Sachar","year":"2021","unstructured":"Sachar R, Soga Y, Ansari MM, Kozuki A, Lopez L, Brodmann M, et al. 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. JACC Cardiovasc Interv. 2021;14(10):1123\u201333.","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"3788_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","volume":"6","author":"F Liistro","year":"2013","unstructured":"Liistro F, Grotti S, Porto I, Angioli P, Ricci L, Ducci K, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013;6(12):1295\u2013302.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"3788_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/1526602817725062","volume":"24","author":"SW de Boer","year":"2017","unstructured":"de Boer SW, van den Heuvel DAF, de Vries-Werson DAB, Vos JA, Fioole B, Vroegindeweij D, et al. Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions. J Endovasc Ther. 2017;24(6):783\u201392.","journal-title":"J Endovasc Ther"},{"issue":"23","key":"3788_CR21","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.116.025329","volume":"135","author":"I Ott","year":"2017","unstructured":"Ott I, Cassese S, Groha P, Steppich B, Hadamitzky M, Ibrahim T, et al. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH). Circulation. 2017;135(23):2218\u201326.","journal-title":"Circulation"},{"issue":"5","key":"3788_CR22","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1177\/0962280213519716","volume":"25","author":"PC Austin","year":"2016","unstructured":"Austin PC, Schuster T. The performance of different propensity score methods for estimating absolute effects of treatments on survival outcomes: A simulation study. Stat Methods Med Res. 2016;25(5):2214\u201337.","journal-title":"Stat Methods Med Res"},{"issue":"28","key":"3788_CR23","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"issue":"1","key":"3788_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00270-014-1024-9","volume":"38","author":"J Lammer","year":"2015","unstructured":"Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial. Cardiovasc Intervent Radiol. 2015;38(1):25\u201332.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"3788_CR25","first-page":"1078","volume":"100","author":"WA Gray","year":"2022","unstructured":"Gray WA, Cardenas J, Teigen CL. Evaluation of safety and efficacy of the S.M.A.R.T.\u00ae Flex Vascular Stent System (OPEN study). Catheter Cardiovasc Interv. 2022;100(6):1078\u201387.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"15","key":"3788_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jacc.2013.05.079","volume":"62","author":"J Lammer","year":"2013","unstructured":"Lammer J, Zeller T, Hausegger KA, Schaefer PJ, Gschwendtner M, Mueller-Huelsbeck S, et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol. 2013;62(15):1320\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3788_CR27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s00270-023-03646-0","volume":"47","author":"K Hausegger","year":"2024","unstructured":"Hausegger K, Kurre W, Schr\u00f6der H, Dambach J, Stahnke S, Loewe C, et al. Long-Term Follow-up and Mortality Rate of Patients of the Randomized Freeway Stent Study. Cardiovasc Intervent Radiol. 2024;47(2):186\u201393.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"3788_CR28","doi-asserted-by":"publisher","first-page":"e025677","DOI":"10.1161\/JAHA.122.025677","volume":"12","author":"Y Soga","year":"2023","unstructured":"Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. J Am Heart Assoc. 2023;12(1):e025677.","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"3788_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2022.06.043","volume":"80","author":"P Krishnan","year":"2022","unstructured":"Krishnan P, Farhan S, Schneider P, Kamran H, Iida O, Brodmann M, et al. Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention. J Am Coll Cardiol. 2022;80(13):1241\u201350.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3788_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1253\/circj.CJ-08-0765","volume":"73","author":"A Koizumi","year":"2009","unstructured":"Koizumi A, Kumakura H, Kanai H, Araki Y, Kasama S, Sumino H, et al. Ten-year patency and factors causing restenosis after endovascular treatment of iliac artery lesions. Circ J. 2009;73(5):860\u20136.","journal-title":"Circ J"},{"issue":"6","key":"3788_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/17434440.2016.1184969","volume":"13","author":"R Colleran","year":"2016","unstructured":"Colleran R, Harada Y, Cassese S, Byrne RA. Drug coated balloon angioplasty in the treatment of peripheral artery disease. Expert Rev Med Devices. 2016;13(6):569\u201382.","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"3788_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacc.2018.11.039","volume":"73","author":"Y Bausback","year":"2019","unstructured":"Bausback Y, Wittig T, Schmidt A, Zeller T, Bosiers M, Peeters P, et al. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease. J Am Coll Cardiol. 2019;73(6):667\u201379.","journal-title":"J Am Coll Cardiol"},{"key":"3788_CR33","doi-asserted-by":"crossref","unstructured":"M\u00fcller-H\u00fclsbeck S, Fanelli F, Haage P, Hamady M, Loffroy R, O'Sullivan G, et al. Re-analysis of old data and new outcomes data do not support a link between paclitaxel coated balloons and paclitaxel eluting stents and mortality: these devices should be used in PAD (Peripheral Arterial Disease) treatment in femoropopliteal disease on the basis of their published efficacy. Cardiovasc Intervent Radiol. 2023;46(8):977\u201380.","DOI":"10.1007\/s00270-023-03507-w"},{"key":"3788_CR34","unstructured":"U.S. Food and drug administration. Update: paclitaxel-coated devices to treat peripheral arterial disease unlikely to increase risk of mortality: letter to health care providers. https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality. Accessed 25 Apr 2026. https:\/\/www.fda.gov\/medical-devices\/letters-health-care-providers\/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality."}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03788-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:28:07Z","timestamp":1782174487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03788-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3788"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03788-1","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (no. [2025]292) on April 22, 2025, with the need for written informed consent waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}